San Francisco: US-based Sorrento Therapeutics has announced that an antibody has demonstrated its ability to completely block SARS-CoV-2 infection of healthy cells in preclinical laboratory experiments. SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The results on Friday showed that Sorrento’s anti-SARS-CoV-2 antibody, STI-1499, completely neutralised the virus infectivity at a very low antibody […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.